ISLAMABAD: The Higher Education Commission (HEC) on Friday said it has initiated a project to revamp its degree attestation system by integrating cutting-edge blockchain technology. “This pivotal ...

RPSC declares final results for Rajasthan State & Subordinate Services Exam. Check merit list, roll numbers, categories, and PDF at rpsc.rajasthan.gov.in. RPSC RAS final Result out: The Rajasthan ...

The Higher Education Commission’s Education Testing Council (ETC) has announced the rescheduling of admission and recruitment tests. The Undergraduate Studies Admission Test (USAT), the Higher ...

The RPSC has announced the RAS mains result 2025, with 2,461 candidates declared successful. The mains exam was held on June 17 and 18, 2025, across multiple centres in Rajasthan in two shifts daily.

One-day court settles real estate case worth Dh900 million without appeal or delay The one-day court in Ras Al Khaimah has delivered a precedent-setting judgment, resolving a civil case valued at ...

New Delhi: UPSC Civil Services Examination is one of the toughest exams in India. Every year, thousands of candidates take this exam. Out of these, a few stand out for their extraordinary performances ...

The answer is no. These Critical Questions use core findings from the academic literature on civil wars and political violence to situate recent tragic events and fundamentally challenge the notion ...

The top job in Pakistani higher education is, by design, a temporary one. The chairperson of the Higher Education Commission (HEC) now gets a mere two years — instead of four — to steward the ...

Bain Capital agreed to sell its data centers in China to Shenzhen Dongyangguang Industry Co. in a transaction valued at about $4 billion. Shenzhen Dongyangguang, the parent of Shanghai-listed ...

Marking a historic milestone, the U.S. Coast Guard announced Monday the combined interdiction of more than 76,140 pounds of illicit narcotics. The quantity of drugs offloaded at Port Everglades is the ...

Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.